Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medica SurB de CVMSURF 82 EV-to-EBITDA is 4.78 as of Jul. 31, 2026, which is 7% below its 10-year median of 5.14. GuruFocus rates MSURF with a GF Score™ of 82/100 and a GF Value™ of $0.53. The stock has 5 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Medica SurB de CV ranks better than 87.82% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medica SurB de CV's enterprise value is $280.8 Mil.
Medica SurB de CV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $58.8 Mil. Therefore, Medica SurB de CV's EV-to-EBITDA for today is 4.78.
The historical rank and industry rank for Medica SurB de CV's EV-to-EBITDA or its related term are showing as below:
MSURF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.6 Med: 5.14 Max: 11.49
Current: 4.42
During the past 13 years, the highest EV-to-EBITDA of Medica SurB de CV was 11.49. The lowest was 1.60. And the median was 5.14.
MSURF's EV-to-EBITDA is ranked better than 87.82% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.04
vs MSURF: 4.42
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Medica SurB de CV (OTCPK:MSURF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medica SurB de CV's PE Ratio (TTM) for today is calculated as:
Medica SurB de CV's share price for today is $0.6733.
Medica SurB de CV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.068.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Medica SurB de CV's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Medica SurB de CV's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medica SurB de CV EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medica SurB de CV's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Medica SurB de CV's EV-to-EBITDA falls into.
Medica SurB de CV's current Enterprise Value is $280.8 Mil.
Medica SurB de CV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $58.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medica SurB de CV (MSURF) has a EV-to-EBITDA of 4.78 as of Jul. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medica SurB de CV. This is near median its historical median of 5.14. Over the past decade, Medica SurB de CV's EV-to-EBITDA has ranged from 1.60 to 11.49. According to the industry distribution chart, Medica SurB de CV ranks #62 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 12.2%.
Is Medica SurB de CV's EV-to-EBITDA too high?
Medica SurB de CV's current EV-to-EBITDA of 4.78 is near median its 10-year median of 5.14. Over the past 10 years, this metric has ranged from a low of 1.60 to a high of 11.49. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.04. Medica SurB de CV's value of 4.78 is 56.7% below this industry median. Based on the distribution chart, Medica SurB de CV ranks #62 out of 509 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medica SurB de CV has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Medica SurB de CV's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medica SurB de CV ranks #62 out of 509 companies for EV-to-EBITDA. This places Medica SurB de CV in the top 12% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 11.04. Medica SurB de CV's value of 4.78 is 56.7% below this benchmark. Historically, Medica SurB de CV's own EV-to-EBITDA has ranged from 1.60 to 11.49 over the past decade. While the company's 10-year median is 5.14 vs. the industry median of 11.04, Medica SurB de CV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.04, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medica SurB de CV's current EV-to-EBITDA of 4.78 is 56.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medica SurB de CV. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medica SurB de CV's current EV-to-EBITDA is 4.78, which is near median its own 10-year median of 5.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medica SurB de CV stock overvalued right now?
Medica SurB de CV (MSURF) has a current EV-to-EBITDA of 4.78. The stock's GF Value™ is $0.53, compared to a current price of $0.67 — trading 27% above its estimated fair value. The current EV-to-EBITDA is 4.78, which is near median its 10-year median of 5.14 and 56.7% below the Healthcare Providers & Services industry median of 11.04. Medica SurB de CV's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Medica SurB de CV (MSURF), the current EV-to-EBITDA is 4.78 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medica SurB de CV (MSURF) Overvalued in 2026?
Based on GuruFocus' analysis, Medica SurB de CV stock appears to be overvalued.
The current stock price of $0.67 is trading 27% above its estimated GF Value™ of $0.53.
Key valuation signals for MSURF:
EV-to-EBITDA: 4.78 (near median its 10-year median of 5.14)
GF Value™: $0.53 vs. price of $0.67 (27% above fair value)
Industry Position: 56.7% below the Healthcare Providers & Services median (#62 of 509)
No single metric tells the full story. See the MSURF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.
82GF Score
Get the complete analysis for MSURF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MSURF has been successfully added to your 
